Yasser Abou Mourad

Pamidronate in the Prevention of Chemotherapy-Induced Bone Loss in Premenopausal Women with Breast Cancer: A Randomized Controlled Trial

Ghada El‐Hajj Fuleihan, Mariana Salamoun, Yasser Abou Mourad et al. · The Journal of Clinical Endocrinology & Metabolism · 2005 · 98 citations · Full text

Medicine, Oncology, Bone Metabolism +16

Dexrazoxane for anthracycline extravasation and GM-CSF for skin ulceration and wound healing

Zaher K. Otrock, Afif Mufarrij, Yasser Abou Mourad et al. · The Lancet Oncology · 2004 · 60 citations

Medicine, Dermatology, Pharmacology +10

A Multicenter Phase II Study Using a Dose Intensified Pegylated-Asparaginase Pediatric Regimen in Adults with Untreated Acute Lymphoblastic Leukemia: A DFCI ALL Consortium Trial

Daniel J. DeAngelo, Kristen E. Stevenson, Donna Neuberg et al. · Blood · 2015 · 48 citations

Medicine, Oncology, Pediatrics +13

Outcome of Patients With Non-Hodgkin Lymphomas With Concurrent MYC and BCL2 Rearrangements Treated With CODOX-M/IVAC With Rituximab Followed by Hematopoietic Stem Cell Transplantation

Haowei Sun, Kerry J. Savage, Aly Karsan et al. · Clinical Lymphoma Myeloma & Leukemia · 2015 · 44 citations

Medicine, Hematology, Oncology +17

Novel agents improve survival of transplant patients with multiple myeloma including those with high-risk disease defined by early relapse (<12 months)

Christopher P. Venner, Joseph M. Connors, Heather J. Sutherland et al. · Leukemia & lymphoma/Leukemia and lymphoma · 2010 · 36 citations

Medicine, Oncology, Pharmacotherapy +15